comprehensive -WSS

comprehensive

author：focus 2025-09-06 03:28:38 - browse：3712

Vincent Major (left) and Cristina Gonzalez at the prompt-a-thon organized by NYU Langone. Courtesy Joe Carrotta/ NYU Langone

NEW YORK — A fourth-year medical student, a music therapist, a child psychiatrist, and a physician-researcher stared at their laptops, puzzling over the combination of words that would make a supposedly intelligent system — NYU Langone’s customized version of ChatGPT — think about health care problems in a way that was useful to them.

As part of a “prompt-a-thon” in August at the medical center’s science building, the group had been charged with analyzing a patient record around the theme of equity using NYU’s HIPAA-compliant implementation of the buzzy OpenAI technology that can interpret language and generate text based on queries.

After a morning of mini-lectures, participants broke off into assigned groups and dove into NYU Langone’s newly launched prompting interface. Representatives from Microsoft, which makes the artificial intelligence tool accessible through its cloud services, were on hand to ensure everything ran smoothly as about 70 workshop participants from across the academic medical center put prompts into the system around themes including research, clinical applications, and patient education.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Physician subsidies by hospitals soar in wake of No Surprises Act

focus

WSS

Researchers tackle phage therapy hurdles for wider adoption

Readout Newsletter: New research from Sanofi, Regeneron, etc.

New CMS data security rules will hurt Medicare, Medicaid research

Testing for cancer recurrence creates a new limbo for patients

Paying for Covid pills will soon shift to insurers

Physician subsidies by hospitals soar in wake of No Surprises Act

explore

comprehensive

knowledge

Trump demands the U.S. pay no more for drugs than other countries … again

FDA warns medical device makers about rise in fabricated data

Medicare details structure of new drug price negotiation program

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

Malaria cases in Florida and Texas: Here’s what you need to know

Cassava reveals details — and problems — with Alzheimer's study

Moonlake's readout produced a cash windfall. Risks remain

WHO may add ‘noma' to its list of neglected tropical diseases

In age of alternative facts, a scholarly course on calling out crap

Hospitals are piloting generative AI tools as regulators play catch

focus

In 'major milestone,' FDA approves first cell therapy for solid tumors

Testing for cancer recurrence creates a new limbo for patients

Medicare Advantage enrollment hits roughly 33.4 million

First Opinion Podcast: How to protect health care in times of war

Eli Lilly to pay $200M for Beam’s stake in gene

Why Sanofi got shellacked over its spinoff

leisure time

focus

leisure time

hotspot